News from rhythm A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 23, 2014, 08:00 ET

Rhythm Presents Clinical Data that RM-493 Increases Energy Expenditure in Obesity Study

 Rhythm announced today the presentation of results from a clinical trial that evaluated the effect of RM-493, the company's novel melanocortin...

May 10, 2014, 15:00 ET
The Heart Rhythm Society 2014 Annual Meeting - Opening Session in San Francisco (PRNewsFoto/Heart Rhythm Society)

Groundbreaking Medical News Presented This Week At Heart Rhythm 2014

 This week at Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th Annual Scientific Sessions, new research was unveiled that will advance...

May 09, 2014, 15:21 ET

New Expert Consensus Statement Attempts To Close The Gap On Guidance For Implantable Cardioverter Defibrillator (ICD) Therapy By Addressing Specific Patient Populations

 The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement...

May 07, 2014, 11:00 ET

Heart Rhythm Society Commences Annual Scientific Sessions In San Francisco Set To Explore The Crossroads Of Technology And Medicine

 Today, Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th Annual Scientific Sessions and this year's premier conference on cardiac...

May 06, 2014, 11:02 ET

Rhythm Presents Positive GI Motility Results for Relamorelin (RM-131) in Phase 2 Chronic Constipation Study

Rhythm announced today the presentation of pharmacodynamic results from a Phase 2 clinical trial with relamorelin (RM-131) for the treatment of...

May 06, 2014, 11:00 ET

Rhythm Presents Positive Phase 2 Study Results for Ghrelin Prokinetic Relamorelin (RM-131) in Diabetic Gastroparesis

 Rhythm announced today the presentation of results from a Phase 2 clinical trial assessing the safety and efficacy of relamorelin (RM-131) in...

Feb 28, 2014, 17:53 ET

Rhythm to Present at the Cowen and Company 34th Annual Health Care Conference

 Rhythm announced today that Keith Gottesdiener, MD, CEO, will present a corporate update at the Cowen and Company 34th Annual Health Care...

Feb 04, 2014, 08:00 ET

"Listen To Your Heart" This February And Take Action To Ensure A Healthier You

 Nearly four million Americans suffer from arrhythmias each yeari. Arrhythmias or heart rhythm disorders affect the electrical system of the...

Sep 24, 2013, 08:00 ET

Rhythm Initiates Clinical Trial of RM-493 for Obesity Caused by Genetic Variant

 Rhythm announced today the initiation of the first of a series of clinical trials with RM-493, the company's novel melanocortin 4 receptor...

Sep 10, 2013, 06:30 ET

Rhythm Awarded $1.35 Million from The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinson's Disease

Rhythm announced today that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded a $1.35 million research grant to Rhythm to...

May 20, 2013, 08:30 ET

Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.

 Rhythm announced today the presentation of results from a new epidemiology study demonstrating a higher prevalence of gastroparesis symptoms...

May 20, 2013, 08:30 ET

Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes

Rhythm announced today the results of a second Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic...

May 08, 2013, 08:00 ET

President Bill Clinton Kicks Off Heart Rhythm 2013 In Denver

 Today, former United States President, Bill Clinton presents the keynote address at the Opening Plenary Session at Heart Rhythm 2013, the...

May 06, 2013, 08:00 ET

Heart Rhythm Society Launches HRS Consulting Services to Help Promote Streamlined Business Solutions and Optimal Patient Care

The Heart Rhythm Society (HRS) Board of Trustees today announced the launch of HRS Consulting Services, a new business entity designed to provide...

May 03, 2013, 08:00 ET

Results Of Groudbreaking "Arrest the Risk" Campaign To Educate African Americans On Sudden Cardiac Arrest To Be Presented At Heart Rhythm Society's 34th Annual Scientific Sessions

 Results from a six-month nationwide effort to educate African Americans about the risk of Sudden Cardiac Arrest (SCA) will be presented at a...

Apr 16, 2013, 06:30 ET

Rhythm Initiates Phase 2 Clinical Trial of Ghrelin Prokinetic RM-131 for Lower GI Functional Disorders

 Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the...

Mar 18, 2013, 09:00 ET

Chicago Organizations Support "Arrest The Risk" Initiative To Educate African Americans About Deadly Impact Of Sudden Cardiac Arrest

 To help Chicago residents understand their risk for sudden cardiac arrest (SCA), the Heart Rhythm Society (HRS), Association of Black...

Feb 12, 2013, 10:12 ET

New Research Shows 'Flutter' Of Inactivity As Americans Ignore Warning Signs Of Atrial Fibrillation

 While the majority of Americans are at least aware of atrial fibrillation (AF), many may be unable to identify or may even ignore the warning...

Feb 05, 2013, 16:51 ET

Heart Rhythm Society And Association Of Black Cardiologists Launch 10-City "Arrest The Risk" Initiative To Educate African Americans About Deadly Impact Of Sudden Cardiac Arrest

 During February Heart Health Month, the Heart Rhythm Society (HRS) and the Association of Black Cardiologists (ABC) are urging consumers,...

Jan 04, 2013, 07:00 ET

Rhythm Initiates Phase 2 Clinical Trial of RM-493 for Obesity

 Rhythm announced today the initiation of a Phase 2 clinical trial with RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, for...